Evidence map›Paper›PMID 23605375›Full record

Trial reportPediatric nephrology (Berlin, Germany)2013

Prednisone in the treatment of tubulointerstitial nephritis in children.

Timo Jahnukainen, Ville Saarela, Pekka Arikoski, Elisa Ylinen, Kai Rönnholm, Marja Ala-Houhala, Matti Nuutinen

Abstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Pediatric nephrology (Berlin, Germany), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Tubulointerstitial nephritis in children and adolescents.Pediatric nephrology (Berlin, Germany) · 2025
    Review
  5. Drugs in treating paediatric acute kidney injury.Pediatric nephrology (Berlin, Germany) · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. [Interstitial nephritis].Der Internist · 2019
    Article
  15. Article
  16. FOXP3Pediatric nephrology (Berlin, Germany) · 2018
    Article
  17. Article
  18. Tubulointerstitial nephritis and uveitis.Current opinion in ophthalmology · 2017
    Review
  19. Tubulointerstitial nephritis: diagnosis, treatment, and monitoring.Pediatric nephrology (Berlin, Germany) · 2017
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Timo JahnukainenDepartment of Paediatric Nephrology and Transplantation, Children's Hospital, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland. timo.jahnukainen@helsinki.fi
Ville Saarela
Pekka Arikoski
Elisa Ylinen
Kai Rönnholm
Marja Ala-Houhala
Matti Nuutinen
Helsinki University Hospital · FIOulu University Hospital · FIKuopio University Hospital · FITampere University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with tubulointerstitial nephritis (TIN) may develop permanent renal impairment. However, there are no prospective studies available on the treatment of TIN.

methodsThe effect of prednisone in the treatment of TIN was evaluated in a total of 17 patients who received prednisone or who were followed up without medication. The patient group was subdivided based on the initial plasma creatinine (PCr), below or above 150 μmol/l.

resultsAll prednisone-treated patients had normal plasma creatinine (PCr) after 1 month of treatment (median 59.1 [45-85] μmol/l) whereas only 50 % of patients in the non-treatment group had normal creatinine (median 81.0 [42-123] μmol/l) at the same time point (p = 0.025). During 6 months' follow-up, PCr decreased in all patient groups; however, it decreased significantly only in prednisone-treated patients with baseline PCr >150 μmol/l (p < 0.001). At the end of follow-up, no difference in PCr, glomerular filtration rate (GFR), or low molecular weight (LMW) proteinuria could be found between the study groups. A considerable number of patients in both groups had subnormal GFR and/or persistent LMW proteinuria at the 6-month follow-up visit. Eighty-two percent of the patients had uveitis.

conclusionsPrednisone speeds up the recovery from renal symptoms of TIN, especially in patients with severe nephritis. The renal function did not differ significantly between prednisone and control patients after 6 months' follow-up.

Indexed as

AdolescentBiomarkersChildChild, PreschoolCreatinineFemaleFinlandFollow-Up StudiesGlomerular Filtration RateGlucocorticoidsHumansKidneyMaleNephritis, InterstitialPrednisoneProspective StudiesBiomarkersCreatinineGlucocorticoidsPrednisone

Identifiers

PMID23605375
OpenAlexW2050014813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.